{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:33:50Z","timestamp":1792704830979,"version":"4.5.0"},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Nucleos(t)ide analogues (<jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>s) and peginterferon have complementary effects in chronic hepatitis B, but it is unclear whether combination therapy improves responses in genotype D\u2010infected patients. We conducted an open\u2010label study of peginterferon alfa\u20102a 180\u00a0\u03bcg\/wk added to ongoing <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content> therapy in hepatitis B e antigen (<jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg)\u2010negative, genotype D\u2010infected patients with hepatitis B virus DNA &lt;20\u00a0IU\/mL. The primary endpoint was proportion of patients with \u226550% decline in serum HBsAg by the end of the 48\u2010week add\u2010on phase. Seventy patients received treatment, 11 were withdrawn at week 24 for no decrease in HBsAg, and 14 withdrew for other reasons. Response rate (per\u2010protocol population) was 67.4% (29\/43) at week 48 (95% confidence interval [CI]: 51, 81) and 50.9% (28\/55) at week 96 (95% CI: 38, 66). Median serum <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg decreased throughout peginterferon alfa\u20102a treatment and was significantly lower than baseline at weeks 48, 72 and 96 (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001). Decreases in <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg of \u22650.5\u2010log<jats:sub>10<\/jats:sub> and \u22651\u2010log<jats:sub>10<\/jats:sub> were documented in 19 (44.2%) and 6 (14.0%) patients at week 48 and 6 (10.9%) and 17 (30.9%) patients at week 96. The proportion of patients with <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg &lt;1000, &lt;500, &lt;100 and &lt;10\u00a0IU\/mL at \u22651 timepoint during treatment was 78.6% (n\u00a0=\u00a044), 57.1% (n\u00a0=\u00a032), 21.4% (n\u00a0=\u00a012) and 7.1% (n\u00a0=\u00a04). Interferon gamma\u2010induced protein 10 increased from baseline up to week 48, with week 12 levels significantly associated with response at week 48. Addition of peginterferon alfa\u20102a to ongoing <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content> therapy significantly decreased <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg levels in <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg\u2010negative patients with genotype D infection (ClinicalTrials.gov NCT01706575).<\/jats:p>","DOI":"10.1111\/jvh.12999","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:48:38Z","timestamp":1536198518000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Add\u2010on peginterferon alfa\u20102a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B \u2018e\u2019 antigen\u2010negative chronic hepatitis B genotype D"],"prefix":"10.1111","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-7476","authenticated-orcid":false,"given":"Pietro","family":"Lampertico","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizia R.","family":"Brunetto","sequence":"additional","affiliation":[{"name":"Internal Medicine Department of Clinical and Experimental Medicine University of Pisa  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Crax\u00ec","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Di.Bi.M.I.S. University of Palermo  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Gaeta","sequence":"additional","affiliation":[{"name":"Infectious Diseases University of Campania Luigi Vanvitelli  Naples Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rizzetto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Rozzi","sequence":"additional","affiliation":[{"name":"Roche SpA  Monza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Colombo","sequence":"additional","affiliation":[{"name":"Clinical and Research Center Humanitas  Rozzano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of The HERMES Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000080872"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040431"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301430"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.018"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.039"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13751"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.09.043"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30189-3"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22760"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22744"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.07.017"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1921"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.039"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.029"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1866"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.08.023"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25749"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.12999","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T01:58:02Z","timestamp":1694656682000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/jvh.12999"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12999","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"2018-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}